Brawn Biotech (BOM:530207) 3-Year EBITDA Growth Rate : -67.40% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Brawn Biotech 3-Year EBITDA Growth Rate?

Brawn Biotech's EBITDA per Share for the three months ended in Mar. 2024 was ₹-1.04.

During the past 3 years, the average EBITDA Per Share Growth Rate was -67.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Brawn Biotech was 91.70% per year. The lowest was -67.40% per year. And the median was 20.45% per year.

Competitive Comparison of Brawn Biotech's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Brawn Biotech's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brawn Biotech's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brawn Biotech's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Brawn Biotech's 3-Year EBITDA Growth Rate falls into.

Brawn Biotech 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Brawn Biotech (BOM:530207) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Brawn Biotech 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Brawn Biotech's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Brawn Biotech (BOM:530207) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brawn Biotech Ltd (BOM:530207) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Plot No. 30, Sector 33, Near Hero Honda Factory, Gurugram, HR, IND, 122001

Website

https://www.brawnbiotech.com

Brawn Biotech Ltd is a healthcare company. It is primarily engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals. It markets pharmaceutical products in India and internationally. The company generates a major portion of its revenue from exports.

Brawn Biotech (BOM:530207) Headlines

No Headlines